Skip to main content
. 2016 Jun 28;38(17):1329–1335. doi: 10.1093/eurheartj/ehw230

Figure 2.

Figure 2

Odds ratio and confidence intervals of adverse events and tachycardia termination of procainamide patients compared with amiodarone patients. AE, adverse events; MCAE, major cardiac adverse events; SP, study period (40 min); OP, observation period (24 h).